Login / Signup

Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with CKD and Type 2 Diabetes: Population-Based US Cohort Study.

Edouard L FuElvira D'AndreaDeborah J WexlerElisabetta PatornoJulie M Paik
Published in: Clinical journal of the American Society of Nephrology : CJASN (2023)
In US patients with CKD and type 2 diabetes receiving routine care, SGLT2i use was associated with higher risks of genital infections and potentially lower limb amputations and nonvertebral fractures.
Keyphrases